[Certain complications caused by the use of external arteriovenous shunt and internal arteriovenous fistula in patients with terminal renal insufficiency kept on regular hemodialysis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001164:Arteriovenous Fistula / Q000150:complications; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007511:Ischemia / Q000209:etiology / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D007688:Kidneys, Artificial; D010447:Peptide Hydrolases / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010447:Peptide Hydrolases
Nekotorye oslozhneniia u bol'nykh s terminal'noĭ pochechnoĭ nedostatochnost'iu na reguliarnom gemodialize, sviazannye s ispol'zovaniem naruzhnogo arterio-venoznogo shunta i vnutrennei arterio-venoznoĭ fistuly